Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract , published online September 2014. DOI: 10.1177/1078155214551315

Makaleler > Editöre Mektup · 2015

Yazarlar: Derya HOPANCI BIÇAKLI, Umut VAROL, Mustafa DEGIRMENCI, Didem TUNALI, Burcu ÇAKAR, İsabel Raika DURUSOY, Burcak KARACA, Ulus Ali ŞANLI, RÜÇHAN USLU

Journal of Oncology Pharmacy Practice, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Scopus, 2015, cilt 21, ss 318-319